PH94B
PH94B-CL030
Phase 3 small_molecule terminated
Quick answer
PH94B for Social Anxiety Disorder is a Phase 3 program (small_molecule) at Vistagen Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vistagen Therapeutics
- Indication
- Social Anxiety Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated